We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Amplified DNA Assays Detect Chlamydia Trachomatis and Neisseria Gonorrhoeae

By LabMedica International staff writers
Posted on 02 Apr 2009
Print article
New technology provides clinical laboratories with extremely reliable detection of Chlamydia trachomatis and Neisseria gonorrhoeae at a high throughput rate using internal extraction control and process verification.

BD Diagnostics (Franklin Lakes, NJ, USA), a segment of BD (Becton, Dickinson and Company) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA; Rockville, MD, USA) for the BD ProbeTec Chlamydia trachomatis (CT) Qx amplified DNA assay and the BD ProbeTec Neisseria gonorrhoeae (GC) Qx amplified DNA assay on the next-generation BD Viper System with XTR Technology.

When tested with the BD Viper System with XTR technology, the BD ProbeTec CT Qx and GC Qx amplified DNA assays use BD ferric oxide, FOX Extraction, and strand displacement amplification technologies for the direct, qualitative detection of Chlamydia and Neisseria DNA.

The fully automated system processes up to 736 patient samples in a single work shift. It offers the least hands-on time for setup, sample extraction, workflow, and maintenance. One operator can fully execute all of the functions required to report results with several BD Viper systems operating concurrently.

The tests are performed on clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens. These assays are indicated for use with asymptomatic and symptomatic individuals to aid in the diagnosis of chlamydial and gonococcal urogenital disease.

BD is a leading global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. The company is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery, and production of new drugs and vaccines.

Related Links:

BD Diagnostics
U.S. Food and Drug Administration



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Dengue Test
Lab Rapid Dengue NS1
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.